Calidi Biotherapeutics, Inc. (CLDI)

NYSE · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Calidi Biotherapeutics, Inc.. Most notable: 2026-06-23: Filed 8-K disclosing director or officer change; 2026-07-16: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing material agreement
  8. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-12Camaisa AllandirectorS8501.46$1,241
2025-08-21Jackson Andrew C.officerP2,5002$5,000
2025-08-21Leftwich ScottdirectorP125,0002$250,000
2025-08-21Poma Eric EdirectorP25,0002$50,000
2025-08-21Schoeneck James AdirectorP75,0002$150,000
2024-12-31Stewart Alan R.directorA12,771
2024-12-31Leftwich ScottdirectorA11,684
2024-12-17Camaisa AllandirectorS10,0001.62$16,200
2024-09-26Camaisa AllandirectorA70,1551.15$80,678
2024-06-28Stewart Alan R.directorA73,437
2024-06-28Schoeneck James AdirectorA79,687
2024-06-28Leftwich ScottdirectorA67,187
2024-03-29Stewart Alan R.directorA25,995
2024-03-29Schoeneck James AdirectorA28,207
2024-03-29Leftwich ScottdirectorA23,783

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings